Tofacitinib clears pediatric alopecia areata in small study

MINNEAPOLIS – The first study to evaluate tofacitinib’s effectiveness at treating severe alopecia areata in the pediatric population found that the janus kinase inhibitor was effective for more than half of the patients, and well tolerated by all. Of a case series of 13 pediatric patients who had...
Source: Skin and Allergy News - Category: Dermatology Source Type: news